Infectious Diseases Elimination

Our programs have established a thematic initiative related to these emerging and re-emerging infectious diseases (ERIDs), allowing us to apply our unique blend of biomedical research and public health expertise to address these diseases.

Burnet Institute has a number of collaborations addressing rising multidrug-resistant tuberculosis and novel diseases like COVID-19, avian influenza and pandemic influenza H1N1 (swine flu) and SARS.

Our programs have established a thematic initiative related to these emerging and re-emerging infectious diseases (ERIDs), allowing us to apply our unique blend of biomedical research and public health expertise to address these diseases.

We are a member of the World Health Organization’s Global Outbreak and Response Network (GOARN).

Research and Public Health Focus

  • Mapping immune response to pandemic influenza in Australia
  • Improving avian influenza capacity of the National Institute of Health and Research Development in Indonesia
  • Monitoring drug-resistant tuberculosis in PNG and neighbouring countries
  • Vaccine development against influenza
  • Identifying novel drug targets and developing antivirals for treatment of respiratory viral pathogens
  • Developing rapid point-of-care tests for the detection of respiratory viruses
  • Molecular epidemiology of ERIDs in Asia and the Pacific regions
  • Studying the determinants of and modelling influenza transmission in households and schools
  • Investigating the transmission of drug-resistant tuberculosis in South Africa
  • Teaching in qualitative and quantitative methods to research ERIDs
  • Providing epidemiological expertise to assist with managing outbreaks of ERIDs.

Contact Details

Professor Heidi Drummer

Co-Program Director, Disease Elimination; Scientific Director, Burnet Diagnostics Initiative; Principal Investigator, Burnet Vaccine Initiative; Co-Head, Viral Entry and Vaccines Group

Telephone

+61392822179

Email

heidi.drummer@burnet.edu.au


Projects

  • ACCESS: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Blood Borne Viruses and Sexually Transmitted Infections

  • EVE-M

  • HCV Elimination Modelling

  • Hepatitis C brief reports

  • Mucosal injury from sexual contact (MISC)

  • Project Geldom

  • The elimination of hepatitis C as a global public health threat

Latest News

    20 December, 2022

    2022 in Review: July to December

    The second half of 2022 saw Burnet launch its 2030 strategy, and continue important work in life sciences, public health and international development.

    20 December, 2022

    2022 in Review: January to June

    As the third year of the pandemic got underway, Burnet continued its COVID-19 advocacy around a vaccines plus approach and advanced important work in malaria, tuberculosis and hepatitis C.